Serum erythropoietin and outcome after ischaemic stroke: a prospective study
N. David Åberg(Sahlgrenska University Hospital), Johan Svensson(National Academy of Medicine), Jörgen Isgaard, Ulf Andréasson(Sahlgrenska University Hospital), Katarina Jood(Sahlgrenska University Hospital), Christina Jern(University of Gothenburg), Christian Blomstrand(University of Gothenburg), Henrik Zetterberg(University of Wisconsin–Madison), Linus Schiöler(University of Gothenburg), Tara M. Stanne(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital)
Cited by 12
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k